Ayr Wellness: Cantor Halves Price Target On Weak Q1 Results

On May 26, Ayr Wellness (CSE: AYR.A) reported its first quarter financial results. The company reported flat quarter-over-quarter revenues at $111.2 million, while adjusted gross profits decreased 8.5% to $57.9 million this quarter. Adjusted EBITDA also saw a sequential decrease going from $26.1 million to $19.5 million. This brought the company’s adjusted EBITDA margin down from 23.3% last quarter to 17.5% this quarter.

The company reported a net loss of $7.57 million, or earnings per share of ($0.11). While the company ended the quarter with $78.66 million in cash and $96.69 million in current liabilities.

Ayr Wellness currently has 8 analysts covering the stock with an average 12-month price target of C$47.88, which represents a 480% upside to the current stock price. Out of the 8 analysts, 2 have strong buy ratings, 5 have buy ratings and a single analyst has a hold rating on the stock. The street high price target sits at C$55, or a 570% upside to the stock price.

Altamira Gold Corp. — sponsored Sponsored · Altamira Gold Corp.

In Cantor Fitzgerald’s note on the results, they reiterate their neutral rating on the stock but slash their 12-month price target on Ayr Wellness from C$13.30 to C$6.75, saying that the discount Ayr trades to its peers is justified. This is because they believe the elevated amount of debt, share-based compensation the company gives, and execution risk.

Additionally, Cantor says that with the multiple compression that has happened in the sector, coupled with federal news flow “being by far the main catalyst,” they are taking a lower-risk approach and prefer to recommend companies with a lower-risk approach and with better breadth/depth, more established operations, and stronger balance sheets.

For the results, Cantor says that they believe 5 states accounted for close to 95% of all sales and that the weighted blend was a 1.6% drop in revenue between the 5 states. The company’s gross margin decrease was primarily attributed to a weakness in the wholesale markets.

They add that financial net debt currently sits at $353 million, but if they include line items such as income taxes payable, deferred income taxes, earn-outs and leases, the net debt almost doubles to $690 million.

Lastly, they note that the company’s free cash flow outflow of $54 million this quarter was almost half of Ayr’s full-year cash flow outflow for 2021. Though management spoke to the idea that the first half of 2022 is front-loaded with capex and the company stockpiled inventory during the first quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

Homeland Nickel Signs Binding Offtake With Westwin for 20,000 Tonnes of Concentrate a Year

Golden Cariboo’s First Quesnelle Resource Estimate Tallies 1.19 Million Gold Equivalent Ounces

Related News

Boeing Sees Canaccord Reiterate Price Target, Buy Rating

In the last weeks, Boeing (NYSE: BA) has been in the news due to its...

Wednesday, July 21, 2021, 02:13:00 PM

Canaccord Genuity Initiates Coverage On Artemis Gold With C$13 Price Target

Canaccord Genuity initiated coverage on Artemis Gold (TSXV: ARTG) this morning with a Speculative Buy...

Thursday, September 10, 2020, 03:00:12 PM

Green Thumb: Analysts Anticipate Q1 Revenues Of US$187.4 Million

Green Thumb Industries (CSE: GTII) announced that they will be reporting their first quarter financials...

Wednesday, May 12, 2021, 11:06:00 AM

Hexo: Analysts Anticipate $34.4 Million In Q3 Revenues

Hexo Corp (TSX: HEXO) (NYSE: HEXO) announced that they will be reporting their fiscal third quarter...

Saturday, June 12, 2021, 01:11:00 PM

Canaccord Reiterates $1.75 Price Target For Mind Medicine Following Roadshow Event

This morning, Canaccord released a flash update for Mind Medicine (NEO: MMED) with highlights from...

Monday, September 28, 2020, 11:02:24 AM